N | Mean of VASI | Standard deviation of VASI | Median of VASI | P value | ||
---|---|---|---|---|---|---|
Total | 173 | 8.62 | 13.09 | 3.8 | ||
Treatment group | General Clinic | 93 | 6.08 | 8.44 | 1.87 | 0.04 |
Phototherapy Clinic | 80 | 8.70 | 9.09 | 6.02 | ||
Gender | Female | 84 | 9.50 | 14.63 | 4.44 | 0.2 |
Male | 89 | 7.80 | 11.43 | 3.18 | ||
Age | 16–19 | 28 | 6.96 | 9.36 | 1.71 | 0.1 |
20–29 | 49 | 7.71 | 11.86 | 4.38 | ||
30–39 | 56 | 7.56 | 11.85 | 3.13 | ||
> = 40 | 40 | 12.38 | 17.47 | 6.7 | ||
Disease duration (years) | <5 | 63 | 3.61 | 5.56 | 1.54 | <0.001 |
5- < 10 | 33 | 7.96 | 8.97 | 3.75 | ||
10- < 15 | 37 | 11.10 | 14.78 | 4.56 | ||
15- < 20 | 13 | 15.34 | 10.70 | 12.87 | ||
> = 20 | 27 | 14.46 | 21.87 | 6.55 | ||
Education | Illiterate | 4 | 19.39 | 11.77 | 17.62 | 0.009 |
Grade 1–11 | 44 | 10.54 | 16.01 | 6.33 | ||
Grade 12 | 76 | 9.12 | 13.68 | 3.22 | ||
University education | 49 | 5.24 | 7.63 | 2.80 | ||
Skin phototype (Fitzpatrick scale) | 1,2 | 4 | 3.97 | 11.77 | 1.64 | 0.2 |
3,4 | 153 | 8.46 | 13.32 | 3.75 | ||
5,6 | 16 | 11.32 | 12.17 | 4.94 | ||
Type of disease | Generalized | 148 | 9.92 | 13.73 | 5.54 | <0.001 |
Localized | 15 | 0.77 | 1.35 | 0.30 | ||
Segmental | 10 | 0.95 | 1.28 | 0.40 | ||
Disease progression | Improving | 82 | 7.49 | 8.51 | 4.90 | 0.6 |
No change | 33 | 11.11 | 21.40 | 3.42 | ||
Slowly progressive | 40 | 10.13 | 13.82 | 3.87 | ||
Rapidly progressive | 18 | 5.81 | 7.55 | 1.84 | ||
Response to treatment | Poor | 50 | 6.69 | 7.41 | 3.31 | 0.4 |
Moderate | 53 | 8.06 | 10.88 | 5.58 | ||
Appropriate | 65 | 10.92 | 17.59 | 4.19 | ||
No treatmenta | 5 | 3.84 | 6.58 | 0.33 | ||
Previous or current psychiatric disease | Yes | 17 | 7.33 | 8.99 | 3.42 | 0.99 |
No | 156 | 8.76 | 13.48 | 4.25 | ||
Another visible skin disorder other than vitiligo | Yes | 9 | 2.52 | 2.76 | 1.59 | 0.04 |
No | 164 | 8.95 | 13.48 | 4.25 |